| Catalog | name | Description | price |
|---|---|---|---|
| R-M2-10105 | Chol-PEG-CKKEEEKKEEEKKEEEK | Cholesterol-PEG-CKKEEEKKEEEKKEEEK is a complex that binds cholesterol (Chol), polyethylene glycol (PEG), and kidney targeted peptide (KTP), mainly used for kidney targeted drug delivery. Its core function is to specifically bind to renal tubular epithelial cells through the negatively charged amino acid sequence of KTP peptide, actively guide nano drugs, liposomes and other carriers to the kidney, increase the accumulation of drugs in renal tissue and reduce the distribution of non target organs. | price> |
| R-M2-10106 | FITC-SS31 | FITC-SS31 is a fluorescein labeled derivative of SS-31 peptide, specifically designed for mitochondrial targeting studies. Advantages: Non membrane potential dependent targeting, does not affect mitochondrial function measurement, suitable for live cells and in vivo experiments. Application scenarios: Observation of mitochondrial dynamics (such as targeted changes under stress). Efficacy evaluation of oxidative stress models (such as H ₂ O ₂, t-BHP treatment). Mechanism research on mitochondrial related diseases such as sepsis and neurodegenerative diseases. | price> |
| R-M2-10111 | Artesunate-PEG2k-SS-cRGDfk | Artesunate-PEG2k-SS-CRGDFk is a bifunctional complex primarily used for tumor targeted therapy and drug delivery systems. Application fields: Tumor treatment: used for delivering chemotherapy drugs, gene drugs, or nucleic acid drugs to improve efficacy and reduce side effects. Drug delivery system: As a modification material for nanocarriers such as liposomes and polymer micelles, it enhances targeting and stability. | price> |
| R-M1-8478 | YIGSR-PEG-N3 | The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice. | price> |
| R-M1-8489 | DMG-PEG-R8 | DMG-PEG-R8,DMG-PEG-octaarginine for enhanced delivery of a bioactive molecule into cells. The PEG2K component may contribute to improved stability and solubility, while the R8 component may aid in cellular uptake. | price> |
| R-M2-10124 | E7(EPLQLKM)-peg-DMG | E7(EPLQLKM)-peg-DMG/DMG-peg-E7(EPLQLKM)/-peg-DMG is an E7 derived peptide modified with PEG-DMG (di nutmeg glycerol polyethylene glycol), mainly used for targeted drug delivery and biological coupling research. Application: Targeted therapy: can be used in combination with chemotherapy drugs or siRNA for targeted therapy of HPV related tumors. Immune regulation: used in vaccine adjuvants or immunotherapy research, by activating the TLR pathway or regulating immune cell function. Biocoupling: As a connecting arm, it is used to construct peptide drug conjugates (PDCs) or nanocarriers. | price> |
| R-M1-8491 | CY5-PEG-iRGD | CY5-PEG-iRGD is a compound designed for targeted delivery and imaging in cancer research. It consists of three components: CY5, a red fluorescent dye for visualization purposes; PEG, a biocompatible polymer that enhances stability and biocompatibility; and iRGD, a peptide sequence that specifically targets tumor cells. | price> |
| R-M2-10126 | DMG-GPQGIAGQR-PEG-CpG-ODN | DMG-GPQGIAGQR-PEG-CpG-ODN is a CpG oligonucleotide modified with PEG and DMG, mainly used in vaccine adjuvant and immunotherapy research. Application: Vaccine adjuvant: can enhance the immunogenicity of vaccines and reduce antigen dosage. Immunotherapy: Used in combination with chemotherapy and radiotherapy to improve the tumor microenvironment. Mechanism research: Used to analyze the TLR9 signaling pathway and immune cell activation mechanism. | price> |
| R-M2-10127 | Chol-GPQGIAGQR-PEG-CpG-ODN | Chol-GPQIAGQR-PEG-CpG-ODN/Cholesterol-GPQGIAGQR-PEG-CpG-ODN is a CpG oligonucleotide modified with cholesterol (Chol), GPQGIAGQR peptide, and PEG2000, mainly used in vaccine adjuvant and immunotherapy research. Application: Vaccine adjuvant: can enhance the immunogenicity of vaccines and reduce antigen dosage. Immunotherapy: Used in combination with chemotherapy and radiotherapy to improve the tumor microenvironment. Mechanism research: Used to analyze the TLR9 signaling pathway and immune cell activation mechanism. | price> |
| R-M2-10130 | E7(EPLQLKM)-peg-Chol | E7 (EPLQLKM)-peg-Chol/E7(EPLQLKM)-peg-Cholesterol/Cholesterol-peg-E7(EPLQLKM) is an E7 derived peptide modified with PEG and cholesterol (Chol), mainly used for targeted drug delivery and biological coupling research. Application: Targeted therapy: Can be coupled with chemotherapy drugs or siRNA for targeted therapy of HPV related tumors. Immune regulation: used in vaccine adjuvant or immunotherapy research by activating the TLR pathway or regulating immune cell function. Biocoupling: As a connecting arm, it is used to construct peptide drug conjugates (PDCs) or nanocarriers. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


